Stockholm - Delayed Quote SEK
SynAct Pharma AB (SYNACT.ST)
16.84
-0.64
(-3.66%)
At close: 5:29:37 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -2.08 | -- |
Revenue Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 230.6M |
| Low Estimate | -- | -- | -- | 230.6M |
| High Estimate | -- | -- | -- | 230.6M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SYNACT.ST | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Related Tickers
ELIC.ST Elicera Therapeutics AB (publ)
6.00
+0.33%
SPRINT.ST Sprint Bioscience AB (publ)
0.4500
+7.91%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.0928
-4.53%
XINT.ST Xintela AB (publ)
0.4940
+0.82%
FLUI.ST Fluicell AB (publ)
11.00
-7.56%
XSPRAY.ST Xspray Pharma AB (publ)
32.10
+0.31%
KAN.ST Kancera AB (publ)
1.1140
-0.54%
EGTX.ST Egetis Therapeutics AB (publ)
4.5100
+6.12%
ATORX.ST Alligator Bioscience AB (publ)
3.9285
+2.56%
LOBE.CN Lobe Sciences Ltd.
0.0350
0.00%